Shao Y, Ma J, Zhang S, Xu Y, Yu H
Nat Plants. 2025; .
PMID: 40087542
DOI: 10.1038/s41477-025-01945-7.
Gao M, Wu Y, Zhang L, Zhou Y, Liu H, Zhang W
Sci Rep. 2025; 15(1):8857.
PMID: 40087295
DOI: 10.1038/s41598-025-92925-6.
Wang H, Xu P, Yin K, Wang S
Front Immunol. 2025; 16:1521196.
PMID: 40066451
PMC: 11891544.
DOI: 10.3389/fimmu.2025.1521196.
Li Y, Liu D, Wang L, Shao Y, Zhou H, Hu Y
Oncogene. 2025; .
PMID: 40038518
DOI: 10.1038/s41388-025-03329-9.
Zhang L, Li Y, Li L, Yao F, Cai M, Ye D
Clin Transl Med. 2025; 15(3):e70239.
PMID: 40008496
PMC: 11862898.
DOI: 10.1002/ctm2.70239.
M6A Demethylase ALKBH5 in Human Diseases: From Structure to Mechanisms.
Fang M, Ye L, Zhu Y, Huang L, Xu S
Biomolecules. 2025; 15(2).
PMID: 40001461
PMC: 11853652.
DOI: 10.3390/biom15020157.
A novel mechanism of FTO modulating the progression of endometriosis through mediating the m6A methylation of GEF-H1 in a YTHDF1-dependent manner.
Ding X, Zhang H, Chen J, Yang M, Huang Z, Lei Y
Mol Med. 2025; 31(1):78.
PMID: 40000966
PMC: 11863856.
DOI: 10.1186/s10020-025-01130-8.
Identification of a novel signature based on RNA methylation-associated anoikis-related genes for predicting prognosis and characterizing immune landscape in colorectal cancer.
Zhu L, Qiu X, Liang S, Huang S, Ning Q, Chen X
Discov Oncol. 2025; 16(1):239.
PMID: 40000539
PMC: 11861771.
DOI: 10.1007/s12672-025-01964-y.
M6A methyltransferase METTL3 promotes glucose metabolism hub gene expression and induces metabolic dysfunction-associated steatotic liver disease (MASLD).
Wang S, Xu Z, Wang Z, Yi X, Wu J
BMC Genomics. 2025; 26(1):188.
PMID: 39994526
PMC: 11853331.
DOI: 10.1186/s12864-025-11377-4.
WTAP-Mediated N6-Methyladenosine Modification Promotes Gastric Cancer Progression by Regulating MAP2K6 Expression.
Han S, Jiang H, Wang J, Li C, Liu T, Xuan M
J Cancer. 2025; 16(5):1420-1437.
PMID: 39991580
PMC: 11843227.
DOI: 10.7150/jca.98559.
The role of N(6)-methyladenosine (m6a) modification in cancer: recent advances and future directions.
Xie X, Fang Z, Zhang H, Wang Z, Li J, Jia Y
EXCLI J. 2025; 24:113-150.
PMID: 39967906
PMC: 11830918.
DOI: 10.17179/excli2024-7935.
Regulatory mechanisms of mA methylation in dilated cardiomyopathy.
Zhang H, Guo H, Han F, Zheng Y
Am J Transl Res. 2025; 17(1):47-59.
PMID: 39959203
PMC: 11826170.
DOI: 10.62347/AOSK8903.
Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications.
Li P, Fang X, Huang D
Eur J Med Res. 2025; 30(1):98.
PMID: 39940056
PMC: 11823136.
DOI: 10.1186/s40001-025-02353-5.
METTL14-mediated mA modification of LINC00340 exerts oncogenic role in retinoblastoma by regulating Notch signaling pathway.
Chen J, Zeng B
Int Ophthalmol. 2025; 45(1):73.
PMID: 39934516
DOI: 10.1007/s10792-025-03449-x.
N-Methyladenosine modification mediated by METTL3 promotes DNA-PKcs expression to induce anlotinib resistance in osteosarcoma.
Zhang Y, Shen G, Zhang D, Meng T, Lv Z, Chen L
Clin Transl Med. 2025; 15(2):e70228.
PMID: 39924638
PMC: 11807765.
DOI: 10.1002/ctm2.70228.
Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO/mA/ANGPTL4/integrin axis in triple-negative breast cancer.
Zhang S, Zhang N, Wan T, He Y, Hao J, Liu Y
J Exp Clin Cancer Res. 2025; 44(1):41.
PMID: 39910592
PMC: 11800637.
DOI: 10.1186/s13046-025-03282-1.
The Mechanism and Latest Progress of m6A Methylation in the Progression of Pancreatic Cancer.
Liu Z, Ma P, He Y, Zhang Y, Mou Z, Fang T
Int J Biol Sci. 2025; 21(3):1187-1201.
PMID: 39897038
PMC: 11781182.
DOI: 10.7150/ijbs.104407.
Identification of and genes and their expression profiling under biotic and abiotic stress in pigeon pea ( [L.] Millspaugh).
Kumari P, Bhattacharjee S, Venkat Raman K, Tilgam J, Paul K, Senthil K
Front Plant Sci. 2025; 15:1521758.
PMID: 39886681
PMC: 11779730.
DOI: 10.3389/fpls.2024.1521758.
Colonic stem cell from severe ulcerative colitis maintains environment-independent immune activation by altering chromatin accessibility and global mA loss.
Liu C, Li J, Jin H, Zhao Q, Li F, Huang Z
Life Med. 2025; 2(4):lnad034.
PMID: 39872548
PMC: 11749566.
DOI: 10.1093/lifemedi/lnad034.
IDO1 inhibits ferroptosis by regulating FTO-mediated m6A methylation and SLC7A11 mRNA stability during glioblastoma progression.
Tian Q, Dan G, Wang X, Zhu J, Chen C, Tang D
Cell Death Discov. 2025; 11(1):22.
PMID: 39863603
PMC: 11762296.
DOI: 10.1038/s41420-025-02293-3.